We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Tumour radiobiology
Poster (Digital)
Radiobiology
RNAi-mediated silencing of PSMA7 sensitizes GBM cells to ionizing radiation and temozolomide
Heather Manring, USA
PO-2218
Radiosensitivity Index as potential marker of biological sex differences to radiation response
Laure Marignol, Ireland
PO-2219
Single cell sequencing is feasible in delineating chemoradiation resistance in rectal cancer
Michelle Or, Australia
PO-2220
In silico model for low dose hyper-radiosensitivity linking mutation induction and cell survival
Balázs Madas, Hungary
PO-2222
Primary stem cell enriched sarcoma cell lines for radiobiological investigations
Franziska Eckert, Austria
PO-2223
Characterization of the RBE of various photon radiation qualities on human cancer cell lines
Naim Chabaytah, Canada
PO-2225
Transcriptome profiling of tumour samples could predict radioresistance in glioblastoma patients
Sergi Serrano, Spain
PO-2226
Uncovering Proton Boron Capture Therapy: In-vitro Cell Irradiation and Monte Carlo Simulations
Villads Lundsteen Jacobsen, Denmark
PO-2227
Five silver atoms clusters enhance radiation sensitivity of pancreatic and glioblastoma cell lines
Waisse WAISSI, France
PO-2229
Ex vivo response markers for radiotherapy treatment personalization of oropharyngeal cancer patients
Iris Lauwers, The Netherlands
PO-2231
Prediction of clonogenic survival following spatial fractionation - a novel 2D quadrat analysis
Delmon Arous, Norway
PO-2232
Reintroducing free radical hydrogen peroxide as potent radiosensitizer in solid tumors
Febe Geirnaert, Belgium
PO-2233
Genetic abnormalities as a predictive factor for neoadjuvant treatment in soft tissue sarcomas
Mateusz Spałek, Poland
PO-2234
Photon and Proton irradiation in Patient-derived, 3D Soft Tissue Sarcoma models: A Pilot Study
Siyer Roohani, Germany
PO-2235